Acadia Pharmaceuticals
ACAD
ACAD
271 hedge funds and large institutions have $3.76B invested in Acadia Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 108 increasing their positions, 84 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
271
Holders Change
-35
Holders Change %
-11.44%
% of All Funds
4.77%
Holding in Top 10
3
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-66.67%
% of All Funds
0.05%
New
45
Increased
108
Reduced
84
Closed
79
Calls
$43.4M
Puts
$102M
Net Calls
-$58.3M
Net Calls Change
-$69.1M
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$36.4M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$30.1M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$25.8M |
| 4 |
HM
HealthCor Management
New York
|
+$23.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$16.5M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$59M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$45.4M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$35M |
| 4 |
Jennison Associates
New York
|
-$31M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$29M |
